Periodic Benefit–Risk Evaluation Report: A Review of Changes

Periodic Benefit–Risk Evaluation Report: A Review of Changes

A periodic benefit–risk evaluation report (PBRER) is a retrospective evaluation document enabling marketing authorisation holders to present the results of a critical analysis of the benefit–risk ratio of a medicinal product. PBRER submission and content requirements changed with the adoption of the...

Full description

Bibliographic Details
Main Authors:	A. R. Titova, N. V. Kosyakina, T. S. Polikarpova, Yu. S. Skorodumova, V. A. Polivanov, K. V. Gorelov
Format:	Article
Language:	Russian
Published:	Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» 2023-03-01
Series:	Безопасность и риск фармакотерапии
Subjects:	pharmacovigilance medicinal product periodic benefit–risk evaluation report pbrer marketing authorisation holder good pharmacovigilance practice periodic safety update report psur
Online Access:	https://www.risksafety.ru/jour/article/view/357

Similar Items

Preparation of a periodic safety update report
by: B. K. Romanov, et al.
Published: (2018-03-01)

Authoring a periodic adverse drug experience report…here's what you need to know!
by: Tejashree N Kulkarni, et al.
Published: (2019-01-01)

Recent changes in the pharmacovigilance system in the Russian Federation and the EAEU
by: G. N. Gildeeva, et al.
Published: (2019-07-01)

Risk Management Plan: An Expert Analysis of Changes to the EAEU Good Pharmacovigilance Practice Requirements for the Content and Submission of the Document
by: T. M. Bukatina, et al.
Published: (2023-03-01)

Expert Evaluation of Pharmacovigilance System Documents Included in the Registration Dossier
by: I. I. Snegireva, et al.
Published: (2020-12-01)

Analysis of Errors Identified during Regulatory Review of Risk Management Plans Submitted as Part of Registration Dossiers
by: A. O. Lovkova, et al.
Published: (2023-12-01)

Analysis of Noncompliances with Legislative Requirements in Pharmacovigilance Materials of Registration Dossiers
by: E. O. Zhuravleva, et al.
Published: (2021-12-01)

Learning Needs as a Reflection of Professional Interests among Health Experts
by: N. G. Goloenko, et al.
Published: (2019-03-01)

Predicting the submission frequency of periodic safety update reports: development and application of the EURD tool
by: María Gordillo-Marañón, et al.
Published: (2024-02-01)

Pharmacovigilance System Master File: An Overview of Changes in the EAEU Good Pharmacovigilance Practice
by: N. Yu. Velts, et al.
Published: (2023-03-01)

Organisation of the Russian Pharmacovigilance System: Survey of Pharmacovigilance Officers
by: A. E. Krasheninnikov, et al.
Published: (2021-10-01)

Signal Management: Updated Requirements of the EAEU Good Pharmacovigilance Practice
by: A. V. Matveev, et al.
Published: (2023-03-01)

Drug safety alerts of pharmacovigilance programme of India: A scope for targeted spontaneous reporting in India
by: Prasad Thota, et al.
Published: (2018-01-01)

New Edition of the EAEU Good Pharmacovigilance Practice: What Has Changed?
by: D. A. Rozhdestvensky
Published: (2023-03-01)

Rate Setting for Labour Costs Related to Pharmacovigilance System Inspections
by: M. Abdrakhmanov, et al.
Published: (2022-04-01)

Preparation for the Inspection of the Pharmacovigilance System
by: B. K. Romanov
Published: (2021-10-01)

A Retrospective Analysis of Reporting of Adverse Drug Reactions in a Tertiary Care Teaching Hospital: One Year Survey
by: Anuj Kumar Pathak, et al.
Published: (2016-08-01)

Critical Overview of the Contents of Risk Management Plans for Medicines
by: T. M. Bukatina, et al.
Published: (2022-04-01)

Adverse drug reactions reporting: Five years analysis from a teaching hospital
by: Vaishali Thakare, et al.
Published: (2022-01-01)

Medication errors associated with the use of cephalosporins
by: Kuzmina A.V., et al.
Published: (2017-02-01)

Changes to the EAEU Guideline on Good Pharmacovigilance Practices
by: B. K. Romanov
Published: (2023-03-01)

Recommendations on Informational Monitoring of the Safety and Efficacy of Medicinal Products in the Russian Federation as Part of Pharmacovigilance
by: K. S. Milchakov
Published: (2022-10-01)

Standard form of a periodic safety update report
by: B. R. Romanov, et al.
Published: (2018-02-01)

Pharmacovigilance for clinical trials in India: Current practice and areas for reform
by: Ballari Brahmachari, et al.
Published: (2011-01-01)

Analysis of fatal outcomes associated with ceftriaxone treatment from the Russian database of spontaneous reports
by: Klabukova D.L., et al.
Published: (2023-06-01)

Knowledge and attitude of health-care professionals toward adverse drug reactions reporting at King Saud Medical City
by: Khaja Moinuddin, et al.
Published: (2018-01-01)

Adverse events following immunisation (AEFI) reports from the Zimbabwe expanded programme on immunisation (ZEPI): an analysis of spontaneous reports in Vigibase® from 1997 to 2017
by: Josiah Tatenda Masuka, et al.
Published: (2019-08-01)

Differences between the European and Eurasian Good Pharmacovigilance Practices
by: A. V. Matveev, et al.
Published: (2021-07-01)

An update on the Pharmacovigilance Programme of India
by: Ratan J Lihite, et al.
Published: (2015-09-01)

Prospects of consumer-initiated adverse drug reaction reporting in cardiovascular pharmacovigilance
by: Vinu Wilson, et al.
Published: (2015-01-01)

Adverse Drug Reaction Reports Regarding Abnormal Behavior After Oseltamivir Use in Children as Reported by Consumers or Healthcare Professionals
by: Noda A, et al.
Published: (2021-03-01)

Case reports as early safety signals: learning from the COVID-19 vaccination campaign
by: Michel Goldman, et al.
Published: (2024-01-01)

Pharmacovigilance and Adverse Drug Reaction Reporting among the General Public in Lithuania: A Cross-Sectional Study
by: Agne Valinciute, et al.
Published: (2023-04-01)

IS THE PATIENT PARTNERSHIP INFORMATIVE IN PHARMACOVIGILANCE?
by: Yu. V. Muravyev
Published: (2017-09-01)

Evaluation of knowledge, attitude, and practice of adverse drug reactions reporting among doctors and nursing staff of a rural tertiary care teaching hospital of Maharashtra
by: Satish E Bahekar, et al.
Published: (2018-01-01)

Development and Validation of a Questionnaire for the Assessment of the Factors that Influence ADR Reporting by Pharmacists
by: Favian Rafif Firdaus, et al.
Published: (2024-02-01)

Qualitative Study of General Public Views towards Adverse Drug Reactions in Lithuania
by: Agne Valinciute-Jankauskiene, et al.
Published: (2021-03-01)

Knowledge, attitude and perception/practices (KAP) of medical practitioners in India towards adverse drug reaction (ADR) reporting
by: Mala Kharkar, et al.
Published: (2012-01-01)

Major Aspects of Detection and Monitoring of Adverse Reactions Associated with Cephalosporin Antibiotic Treatment
by: E. Yu. Demchenkova, et al.
Published: (2021-03-01)

A questionnaire study on the knowledge, attitude, and the practice of pharmacovigilance among the healthcare professionals in a teaching hospital in South India
by: Sandeep Kumar Gupta, et al.
Published: (2015-01-01)